CSL Company
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
Technology:
Image-Based & Radiology Diagnostics
Industry:
Deep Diagnostics
Headquarters:
Parkville, New South Wales, Australia
Founded Date:
01.01.1916
Employees Number:
10001+
Funding Status:
M&A
Estimated Revenue:
$1B to $10B
Last Funding Date:
2004-02-06
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership